Article (Scientific journals)
Info-congres. Essai de prevention du diabete de type 1 par le nicotinamide: les lecons positives d'un essai clinique negatif (ENDIT).
Philips, Jean-Christophe; Scheen, André
2002In Revue Médicale de Liège, 57 (10), p. 672-5
Peer reviewed
 

Files


Full Text
200210_11.pdf
Publisher postprint (474.36 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Diabetes Mellitus, Type 1/prevention & control; Evidence-Based Medicine; Humans; Multicenter Studies as Topic; Niacinamide/pharmacology; Placebos; Randomized Controlled Trials as Topic; Research Design; Risk Factors
Abstract :
[en] ENDIT ("European Nicotinamide Diabetes Intervention Trial") is a large placebo-controlled randomised clinical trial that aimed at studying the efficacy of nicotinamide in the prevention of type 1 diabetes mellitus among first-degree relatives of type 1 diabetic patients with positive islet cell antibodies (ICA). The results presented at the last congress of the European Association for the Study of Diabetes (EASD) in Budapest do not evidence any significant difference in the risk of developing overt diabetes mellitus in the patients treated with nicotinamide (n = 274) as compared to those receiving placebo (n = 275) after 5 years of follow-up. Despite these negative results, positive lessons could be drawn from ENDIT: 1) the feasibility of a large long-standing multicentre European trial in a difficult research area; 2) the importance of large randomised controlled clinical trials to bring the evidence requested by "Evidence-Based Medicine"; 3) the predictive value of various risk markers to progress toward type 1 diabetes in first-degree relatives, especially the number of positive auto-antibodies; and 4) the urgent need to continue intensive research in this important field of preventive medicine.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Philips, Jean-Christophe ;  Centre Hospitalier Universitaire de Liège - CHU > Diabétologie,nutrition, maladies métaboliques
Scheen, André  ;  Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Language :
French
Title :
Info-congres. Essai de prevention du diabete de type 1 par le nicotinamide: les lecons positives d'un essai clinique negatif (ENDIT).
Alternative titles :
[en] Info-congress. Study of the prevention of type 1 diabetes with nicotinamide: positive lessons of a negative clinical trial (ENDIT)
Publication date :
2002
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Volume :
57
Issue :
10
Pages :
672-5
Peer reviewed :
Peer reviewed
Additional URL :
Available on ORBi :
since 08 April 2009

Statistics


Number of views
304 (1 by ULiège)
Number of downloads
305 (1 by ULiège)

Scopus citations®
 
11
Scopus citations®
without self-citations
8

Bibliography


Similar publications



Contact ORBi